APA (7th ed.) Citation

DE, H., JS, K., S, J., YT, L., S, V., K, S., . . . DB, H. (2025). Ketamine Versus Midazolam as the First-Line Continuous Infusion for Status Epilepticus in Children with Cardiac Disease. Neurocritical care, 43(1), 130. https://doi.org/10.1007/s12028-025-02212-5

Chicago Style (17th ed.) Citation

DE, Horvat, et al. "Ketamine Versus Midazolam as the First-Line Continuous Infusion for Status Epilepticus in Children with Cardiac Disease." Neurocritical Care 43, no. 1 (2025): 130. https://doi.org/10.1007/s12028-025-02212-5.

MLA (9th ed.) Citation

DE, Horvat, et al. "Ketamine Versus Midazolam as the First-Line Continuous Infusion for Status Epilepticus in Children with Cardiac Disease." Neurocritical Care, vol. 43, no. 1, 2025, p. 130, https://doi.org/10.1007/s12028-025-02212-5.